XXI Earnings & Financial Statements
XXI
$6.09
+$0.09(+1.59%)
25
Overall
--
Value
41
Tech
10
Quality
Market Cap
$3.58B
Volume
886.38K
52W Range
$4.15 - $12.51
Target Price
--
XXI earnings and financial statements: XXI's income statement, balance sheet and cash flow statement, annual and quarterly.
XXI Annual Financial Statements
| Fiscal year | 2025 | 2025 |
|---|---|---|
| Operating income | -$14.56M | -$51.8K |
| EBITDA | -$216.96M | -$51.8K |
| Net income | -$217.34M | -$51.8K |
| EPS (diluted) | - | $-51800.00 |
| Fiscal year | 2025 | 2025 |
|---|---|---|
| Total assets | $3.93B | - |
| Total liabilities | $486.81M | $51.8K |
| Shareholders’ equity | $3.44B | -$51.8K |
| Cash and equivalents | $117.70M | - |
| Long-term debt | $484.33M | - |
| Fiscal year | 2025 | 2025 |
|---|---|---|
| Operating cash flow | -$2.37M | - |
| Capital expenditure | -$713.20M | - |
| Free cash flow | -$715.57M | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XXI | $6.09 | +1.6% | 886.38K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |